York M. Faulkner
AstraZeneca, Shionogi Pharmaceuticals v. Par Pharmaceutical, Inc. et al. – Represented AstraZeneca and Shionogi in multiple ANDA challenges to Orange Book listed patents covering their Crestor® pharmaceutical product.
GlaxoSmithKline v. Alphapharm et al. – Represented GlaxoSmithKline in multiple ANDA challenges to Orange Book listed patents covering its Paxil® pharmaceutical product.
Microunity Systems Engineering, Inc. v. Sony Corp. – Successfully defended Sony Computer Entertainment America in lawsuit accusing Sony PlayStation products of infringing computer architecture patents.
Littelfuse, Inc. v. Pacific Engineering Corp. of Japan – Successfully represented Pacific Engineering in lawsuit accusing Pacific Engineering blade fuse products of infringing design patents.
Robert Bosch v. TRW Automotive – Represented Bosch in a patent infringement litigation in Arizona enforcing Robert Bosch Corporation’s patent portfolio on automotive crash sensors; resulted in favorable claim construction ruling leading to a monetary award.
Monsanto Co. v. Syngenta Seeds – Represented defendant in patent litigation involving glyphosate-resistant transgenic corn, leading to summary judgment of non-infringement and patent invalidity, which was later affirmed by the Federal Circuit.
Rolls-Royce v. United Technologies Corp. – Member of litigation team that defended United Technologies Corp. in a patent infringement action concerning swept fan blades for ducted gas turbine engines used on contemporary commercial and private aircraft, resulting in a favorable summary judgment ruling of noninfringement in favor of UTC.
Ronald A. Katz Technology Licensing, L.P. v. FedEx Corp. – Represented FedEx in a complete defense victory in case involving claims of infringement of a large patent portfolio related to interactive voice response systems, following consolidation in multidistrict litigation (MDL), favorable summary judgment rulings, an appeal to the U.S. Court of Appeals for the Federal Circuit, and opinions from the Patent Trials and Appeal Board (PTAB) on reexamination requests, and after patent owner Ron Katz reportedly earned approximately $1 billion in license fees from over 150 companies.
Shionogi Pharmaceuticals v. Apotex/Sandoz – Successfully represented Shionogi Pharmaceuticals in multiple ANDA challenges to Orange Book listed patents covering its Doribax® pharmaceutical product.
LG Electronics v. Iridian Technologies – Secured favorable settlement of complex iris scanner technology litigation involving infringement, trade secret, contract, antitrust, unfair competition, and Foreign Corrupt Practices Act claims and counterclaims.